Alkermes
ALKS
Alkermes plc is a biopharmaceutical company that focuses on central nervous system (CNS) diseases such as such as schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), t …
Insider trades and stock quote 2024-2026
All insider trades at Alkermes
More Details
Date
Type
Insider
Position
Ø-Price
Volume
8/3/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$48.6
$98,812
8/3/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$48.6
$437,220
8/3/2026
Sell
Snyderman, Nancy Lynn Md
Director
$50.3
$2,239,076
7/6/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$54.0
$109,897
7/1/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$51.8
$463,621
6/12/2026
Sell
Wright, Christopher I.
Director
$45.1
$90,200
6/4/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$43.0
$87,564
6/1/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$41.7
$375,044
5/29/2026
Sell
Parisi, Samuel Joseph
VP, Finance (Interim PAO)
$42.4
$687,007
5/4/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$33.2
$67,529
5/1/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$33.4
$300,560
4/6/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$34.6
$70,315
4/1/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$35.5
$319,604
3/3/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$29.8
$60,532
3/2/2026
Sell
Gaffin, David Joseph
EVP, CLO, Alkermes, Inc.
$29.3
$59,576
3/2/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$29.7
$267,485
3/2/2026
Sell
Nichols, Christian Todd
SVP, Chief Commercial Officer
$30.0
$180,000
3/2/2026
Sell
Parisi, Samuel Joseph
VP, Finance (Interim PAO)
$29.3
$201,808
2/2/2026
Sell
Cooke, Shane
Director
$34.6
$2,115,672
2/2/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$33.9
$305,385
1/8/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$30.0
$150,005
1/2/2026
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$28.0
$112,000
12/3/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$30.0
$112,447
12/1/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$29.3
$117,200
11/3/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$30.4
$273,442
10/15/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$31.5
$283,776
6/10/2025
Sell
Nichols, Christian Todd
SVP, Chief Commercial Officer
$31.1
$103,654
6/9/2025
Sell
Nichols, Christian Todd
SVP, Chief Commercial Officer
$32.0
$106,489
2/28/2025
Sell
Parisi, Samuel Joseph
VP, Finance (Interim PAO)
$34.0
$65,892
2/25/2025
Sell
Parisi, Samuel Joseph
VP, Finance (Interim PAO)
$35.3
$131,978
2/20/2025
Sell
Parisi, Samuel Joseph
VP, Finance (Interim PAO)
$35.7
$47,361
2/13/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$35.0
$5,130,697
2/12/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$33.0
$6,718,278
1/30/2025
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$32.0
$3,234,382
12/9/2024
Sell
Laurencin, Cato T.
Director
$31.8
$85,708
12/9/2024
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$32.1
$1,961,406
12/5/2024
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$31.5
$290,462
12/4/2024
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$30.8
$441,550
11/27/2024
Sell
Nichols, Christian Todd
SVP, Chief Commercial Officer
$29.2
$151,813
11/11/2024
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$30.1
$1,774,576
11/6/2024
Sell
Hopkinson, Craig C.
EVP R&D, Chief Medical Officer
$29.5
$309,169
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address